Photo(chemo)therapy in private practice in Belgium, France and The Netherlands

Photodermatology Photoimmunology and Photomedicine

Volumn 15, Issue 2, 1999, Pages 59-63

  Faguer, K ^b   Roelandts, R ^b   Dompmartin, A ^b   Van Der Veen, W ^b   Coster, J ^b   Stoof, T ^b   Van Der Valk, P ^b   Leroy, D ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

Photochemotherapy; Phototherapy; PUVA; UVB therapy

Indexed keywords

ARSENIC; METHOXSALEN;

ARTICLE; BELGIUM; FRANCE; HUMAN; NETHERLANDS; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRIVATE PRACTICE; PSORIASIS; PUVA; QUESTIONNAIRE; RADIATION DOSE; SAFETY; ULTRAVIOLET RADIATION;

EID: 0032934186     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.1999.tb00058.x     Document Type: Article

References (36)

1. Mortazawi SAM, Oberste-Lehn H. Lichtsensibilisatoren und ihre therapeutischen Fähigkeiten. Z Haut-Geschlkr 1973: 48: 1-9.
2. Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med 1974: 291: 1207-1211.
3. Fisher T. UV-light treatment of psoriasis. Acta Derm Venereol 1976: 56: 473-479.
4. Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol 1981: 76: 359-362.
5. Van Weelden H, Baart de la Faille H, Young E. A new development in UVB phototherapy of psoriasis. Br J Dermatol 1988: 119: 11-19.
6. Drake LA, Ceilley RI, Dorner W et al. Guidelines of care for phototherapy and photochemotherapy. J Am Acad Dermatol 1994: 31: 643-648.
7. British Photodermatology Group: British Photodermatology Group guidelines for PUVA. Br J Dermatol 1994: 130: 246-255.
8. Diffey BL, Challonner AVJ, Key PJ. A survey of the ultraviolet radiation emissions of photochemotherapy units. Br J Dermatol 1980: 102: 301-306.
9. Henseler T, Hönigsmann H, Wolff K, Christophers E. Oral 8-methoxypsoralen photochemotherapy of psoriasis. The european PUVA study: a cooperative study among 18 European centres. Lancet 1981: I: 853-857.
10. Farr PM, Diffey BL. PUVA treatment of psoriasis in the United Kingdom. Br J Dermatol 1991: 124: 365-367.
11. Calzavara-Pinton PG, Rastrelli M, Carlino A, De Costanza F, Varotti C, De Panfilis G. PUVA treatment of psoriasis in Italy (letter). Br J Dermatol 1992: 127: 548.
12. Dootson G, Norris PG, Gibson CJ, Diffey BL. The practice of ultraviolet phototherapy in the United Kingdom. Br J Dermatol 1994: 131: 873-877.
13. Roelandts R. van der Veen JPW, Coster JE, Stoof TJ, van der Valk PGM. Enquête over lichttherapie bij de Nederlandse en Vlaamse dermatologen. Ned T Dermatol Venereol 1998: 8: 83-85.
14. Buckley DA, Healy E, Rogers S. A comparison of twice-weekly MPD-PUVA and three times-weekly skin typing-PUVA regimens for the treatment of psoriasis. Br J Dermatol 1995: 133: 417-422.
15. Collins P, Wainwright NJ, Amorim I, Lakshmipathi T, Ferguson J. 8-MOP PUVA for psoriasis: a comparison of a minimal phototoxic dose-based regimen with a skin-type approach. Br J Dermatol 1996: 135: 248-254.
16. Sakuntabhai A, Diffey BL, Farr PM. Calculation of 8-methoxypsoralen dose according to body surface area in PUVA treatment. Br J Dermatol 1995: 133: 919-923.
17. Stern RS and Members of the Photochemotherapy Follow-up Study. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. N Engl J Med 1990: 322: 1093-1097.
18. Lindelöf B, Sigurgeirsson B, Tegner E et al. PUVA and cancer: a large-scale epidemiological study. Lancet 1991: 338: 91-93.
19. Lever LR, Farr PM. Skin cancers or premalignant lesions occur in half of high-dose PUVA patients. Br J Dermatol 1994: 131: 215-219.
20. McKenna KE, Patterson CC, Handley J, McGinn S, Allen G. Cutaneous neoplasia following PUVA therapy for psoriasis. Br J Dermatol 1996: 134: 639-642.
21. Buckley DA, Rogers S. Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo. Clin Exp Dermatol 1996: 21: 43-45.
22. Maier H, Schemper M, Ortel B, Binder M, Tanew A, Hönigsmann H. Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients. Dermatology 1996: 193: 185-191.
23. Stern RS, Nichols KT, Väkevä LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). N Engl J Med 1997: 336: 1041-1045.
24. Lowe NJ, Weingarten D, Bourget T, Moy LS. PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen. J Am Acad Dermatol 1986: 14: 754-760.
25. Collins P, Rogers S. Bath-water compared with oral delivery of 8-methoxypsoralen PUVA therapy for chronic plaque psoriasis. Br J Dermatol 1992: 127: 392-395.
26. Roelandts R. Comparing results from different PUVA centers. J Am Acad Dermatol 1984: 11: 522-523.
27. Morison WL. Control of ultraviolet radiation treatment dose in phototherapy and photochemotherapy irradiation equipment. Photodermatology 1987: 1: 60-61.
28. Roelandts R. Quelques considérations concernant les cabines, les lampes et les dosimètres UVA utilisés en photochimiothérapie. Nouv Dermatol 1987: 6: 278-280.
29. Roelandts R, Diffey BL, Bocquet JL. Une dosimétrie UVA précise en photobiologie et en photodermatologie est-elle une illusion? Ann Dermatol Venereol 1988: 115: 1261-1264.
30. Lerman S, Megaw J, Willis I. Potential ocular complications from PUVA therapy and their prevention. J Invest Dermatol 1980: 74: 197-199.
31. Boukes RJ, Bruynzeel DP. Ocular findings in 340 long-term treated PUVA patients. Photodermatology 1985: 2: 178-180.
32. Thomas P, Mignolet G, Bocquet JL. Protection oculaire et PUVA thérapie. Nouv Dermatol 1990: 9: 550-552.
33. Leow YH, Tham SN. UV-protective sunglasses for UVA irradiation protection. Int J Dermatol 1995: 34: 808-810.
34. Garbis H, Elefant E, Bertolotti E, Robert E, Serafinis MA, Prapas N. Pregnancy outcome after periconceptional and first-trimester exposure to methoxsalen photochemotherapy. Arch Dermatol 1995: 131: 492-493.
35. Burger PM, Tijssen JGP, Suurmond D. Photochemotherapy of psoriasis. Clinical study of clearing and long-term maintenance treatment. Dermatologica 1981: 163: 213-228.
36. Fischer T. PUVA: how to use it for maintenance. Semin Dermatol 1992: 11: 287-290.